Status:
COMPLETED
Detection of Ischemia in Asymptomatic Diabetics
Lead Sponsor:
Yale University
Collaborating Sponsors:
Bristol-Myers Squibb
Astellas Pharma US, Inc.
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
50-75 years
Brief Summary
Asymptomatic subjects with Type 2 Diabetes Mellitus were randomized to either screening with Tc-99m sestamibi adenosine SPECT imaging or no screening. All patients will be followed for 5 years for the...
Eligibility Criteria
Inclusion
- Age 50-75 years
- Type 2 diabetes mellitus
Exclusion
- Angina or anginal equivalent
- Abnormal rest ECG (Q or ST depression)
- Known CAD
- Stress testing within the last 3 years
Key Trial Info
Start Date :
August 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
1123 Patients enrolled
Trial Details
Trial ID
NCT00769275
Start Date
August 1 2000
End Date
January 1 2008
Last Update
October 9 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale University School of Medicine
New Haven, Connecticut, United States, 06520